Clinical Trial Update: Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1 and Phase 2 trial updates assess the use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided liver surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Neoplasms

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Centre Leon Berard | Conditions: Liver Neoplasms | Phase 1, Phase 2 | Status: COMPLETED